UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 1 filers reported holding ASSERTIO THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$114,790,000
-1.3%
89,680
+166.1%
0.00%
Q2 2019$116,251,000
-53.4%
33,696
-31.5%
0.00%
Q1 2019$249,277,000
+40.4%
49,1670.0%0.00%
Q4 2018$177,493,00049,1670.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
AlphaMark Advisors, LLC 37$00.00%
View complete list of ASSERTIO THERAPEUTICS INC shareholders